Radiopharmaceutical need between the clinic and regulatory agencies: how philosophy could explain 'the road taken' Stefano BoschiSergio Todde Editorial 03 May 2023 Pages: 2921 - 2924
Defining the role of nuclear medicine in haematological tumours—EANM Focus 4: consensus on molecular imaging and therapy in haematological tumours Cristina NanniCarsten KobeJolanta Kunikowska Editorial 26 June 2023 Pages: 2925 - 2926
PET/MRI in practice: a clinical centre survey endorsed by the European Association of Nuclear Medicine (EANM) and the EANM Forschungs GmbH (EARL) Niek H. J. PrakkenFlorent L. BessonRiemer H. J. A. Slart Editorial 28 June 2023 Pages: 2927 - 2934
Fibroblast activation protein (FAP)-targeted radionuclide therapy: which ligand is the best? Rubel ChakravartyWenyu SongWeibo Cai Editorial 15 July 2023 Pages: 2935 - 2939
PET imaging of tumor vascular normalization in hepatocellular carcinoma Shuxian AnJianjun LiuWeijun Wei Editorial 17 July 2023 Pages: 2940 - 2943
GCP III is not the “off-target” for urea-based PSMA ligands Zhenghong LeeWarren D. HestonJames P. Basilion Letter to the Editor Open access 16 May 2023 Pages: 2944 - 2946
Response to: GCP III is not the “off-target” for urea-based PSMA-ligands Gabriele BassiSamuele CazzamalliDario Neri Letter to the Editor 21 June 2023 Pages: 2947 - 2949
Intriguing information from recent letter and article regarding unwanted targeting of salivary glands by PSMA ligands Steve S. HuangFrank DiFilippoWarren D. W. Heston Letter to the Editor 03 July 2023 Pages: 2950 - 2951
Preclinical evaluation of 68Ga-radiolabeled trimeric affibody for PDGFRβ-targeting PET imaging of hepatocellular carcinoma Huawei CaiZhao LiXiaofeng Lu Original Article Open access 31 May 2023 Pages: 2952 - 2961
In vivo evaluation of a novel 18F-labeled PET radioligand for translocator protein 18 kDa (TSPO) in monkey brain Xuefeng YanFabrice G. SiméonPaolo Zanotti-Fregonara Original Article Open access 30 May 2023 Pages: 2962 - 2970
The use of single-timepoint images to link administered radioiodine activity (MBq) to a prescribed lesion radiation-absorbed dose (cGy): a regression-based prediction interval tool for the management of well-differentiated thyroid cancer patients Audrey MauguenRavinder K. GrewalSteven M. Larson Original Article Open access 12 May 2023 Pages: 2971 - 2983
The predictive value of pretherapy [68Ga]Ga-DOTA-TATE PET and biomarkers in [177Lu]Lu-PRRT tumor dosimetry Azadeh AkhavanallafAvery B. PetersonYuni K. Dewaraja Original Article 12 May 2023 Pages: 2984 - 2996
The relationship between tumour dosimetry, response, and overall survival in patients with unresectable Neuroendocrine Neoplasms (NEN) treated with 177Lu DOTATATE (LuTate) R. AlipourP. JacksonG. Kong Original Article Open access 15 May 2023 Pages: 2997 - 3010
Molecular imaging of arterial fibroblast activation protein: association with calcified plaque burden and cardiovascular risk factors Aleksander KosmalaSebastian E. SerflingRudolf A. Werner Original Article Open access 06 May 2023 Pages: 3011 - 3021
A machine learning method integrating ECG and gated SPECT for cardiac resynchronization therapy decision support Fernando de A. FernandesKristoffer LarsenClaudio T. Mesquita Original Article 17 May 2023 Pages: 3022 - 3033
Excretion of glucose analogue with SGLT2 affinity predicts response effectiveness to sodium glucose transporter 2 inhibitors in patients with type 2 diabetes mellitus Barbara Katharina GeistHelmut BrathSazan Rasul Original Article Open access 17 May 2023 Pages: 3034 - 3041
FAP expression in alpha cells of Langherhans insulae—implications for FAPI radiopharmaceuticals’ use Margarita KirienkoGiovanni CentonzeMassimo Milione Short Communication 04 May 2023 Pages: 3042 - 3049
Head-to-head comparison of different classes of FAP radioligands designed to increase tumor residence time: monomer, dimer, albumin binders, and small molecules vs peptides Jacopo MillulLennart KoepkeMelpomeni Fani Original Article Open access 01 June 2023 Pages: 3050 - 3061
Melanin-targeted [18F]-PFPN PET imaging for prognosticating patients with melanoma Xiao ZhangZhaoguo LinXiaoli Lan Original Article 16 May 2023 Pages: 3062 - 3071
Biodistribution and radiation dosimetry in cancer patients of the ascorbic acid analogue 6-Deoxy-6-[18F] fluoro-L-ascorbic acid PET imaging: first-in-human study Yali LongChang YiZhihao Zha Original Article 16 May 2023 Pages: 3072 - 3083
Machine learning identifies multi-parametric functional PET/MR imaging cluster to predict radiation resistance in preclinical head and neck cancer models Simon BoekeRené M. WinterDaniela Thorwarth Original Article Open access 06 May 2023 Pages: 3084 - 3096
[18F]MFBG PET/CT outperforming [123I]MIBG SPECT/CT in the evaluation of neuroblastoma Peipei WangTuo LiFang Li Original Article 09 May 2023 Pages: 3097 - 3106
Relationship between SUVmax on 18F-FDG PET and PD-L1 expression in hepatocellular carcinoma Xiang ZhouYongquan HuJianjun Liu Original Article 06 May 2023 Pages: 3107 - 3115
Preclinical and pilot clinical evaluation of a small-molecule carbonic anhydrase IX targeting PET tracer in clear cell renal cell carcinoma Wenjia ZhuXiaoyuan LiLi Huo Original Article 29 May 2023 Pages: 3116 - 3125
A prospective head-to-head comparison of [68Ga]Ga-P16-093 and [68Ga]Ga-PSMA-11 PET/CT in patients with primary prostate cancer Guochang WangLinlin LiZhaohui Zhu Original Article 26 May 2023 Pages: 3126 - 3136
Development and external validation of a multivariable [68Ga]Ga-PSMA-11 PET-based prediction model for lymph node involvement in men with intermediate or high-risk prostate cancer Urs J. MuehlematterLilit SchweigerIrene A. Burger Original Article Open access 01 June 2023 Pages: 3137 - 3146
Bladder paraganglioma detection with [18F]MFBG PET/CT: a superior alternative to [68Ga]Ga-DOTATATE Peipei WangTuo LiHongli Jing Image of the Month 22 April 2023 Pages: 3147 - 3148
Metastatic melanoma extending along the inferior vena cava to its branches and venous plexus: a rare route metastasis characterized by [18F]FDG PET/CT Wenlan ZhouXiangzhao LiHubing Wu Image of the Month 24 April 2023 Pages: 3149 - 3150
Sarcoidosis mimicking nodal manifestations of marginal zone lymphoma Johanna S. EnkeNic G. ReitsamAlexander Dierks Image of the Month Open access 26 April 2023 Pages: 3151 - 3152
A pharmacological imaging challenge based on 11C-buprenorphine PET-MRI to explore the response to opioids in humans Claire LeroySébastien GoutalNicolas Tournier Image of the Month 06 May 2023 Pages: 3153 - 3154
Molecular imaging phenotyping of germline fumarate hydratase (FH) pathogenic variant-positive metastatic pheochromocytoma Alessio ImperialeMiriam PepponiBernard Goichot Image of the Month 09 May 2023 Pages: 3155 - 3156
Correction to: EANM enabling guide: how to improve the accessibility of clinical dosimetry Jonathan GearCaroline StokkePablo Minguez Gabiña Correction Open access 29 June 2023 Pages: 3157 - 3158
Correction to: One‑stop [18F]FDG and [68Ga]Ga‑DOTA‑FAPI‑04 total‑body PET/CT examination with dual‑low activity: a feasibility study Guobing LiuWujian MaoHongcheng Shi Correction 01 July 2023 Pages: 3159 - 3159